Article
RU-486 (Mifepristone) ameliorates diabetes but does not correct deficient beta-adrenergic signalling in adipocytes from mature C57BL/6J-ob/ob mice.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity - 1 Oct 1997
Gettys T W, Watson P M, Taylor I L, Collins S
Abstract excerpt
OBJECTIVE: To investigate the role of hypercorticism in the development of compromised beta-adrenergic signalling in adipocytes of mature C57BL/6J-ob/ob mice. DESIGN AND EXPERIMENTAL UNITS: Mature male ob/ob mice and their lean littermates were treated with vehicle or the specific glucocorticoid...
Topics
- Adenylyl Cyclases
- Adipose Tissue
- Adrenergic beta-Agonists
- Animals
- Blood Glucose
- Blotting, Northern
- Blotting, Western
- Colforsin
- Diabetes Mellitus, Experimental
- Dose-Response Relationship, Drug
